Aquestive completes FDA meeting on Anaphylm drug application

March 30, 2026 7:00 AM

Aquestive Therapeutics Inc. (NASDAQ: AQST) announced it completed a Type A meeting with the U.S. Food and Drug Administration regarding ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found